Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AnaptysBio, Inc. - Common Stock (NQ:ANAB)

55.84 +0.56 (+1.01%)

Streaming Delayed Price Updated: 4:00 PM EDT, Sep 2, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	421,732
Open	56.13
Bid (Size)	22.21 (100)
Ask (Size)	68.00 (100)
Prev. Close	55.28
Today's Range	54.66 - 57.90
52wk Range	11.40 - 72.36
Shares Outstanding	27,433,359
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference

September 01, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio (NASDAQ:ANAB): High Growth Momentum Aligns With a Breakout Setup ↗

August 19, 2026

Via Chartmill

Performance

YTD	+86.3%	+86.3%
1 Month	+4.1%	+4.1%
3 Month	+9.0%	+9.0%
6 Month	+38.3%	+38.3%
1 Year	+306.4%	+306.4%

More News

A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next

July 15, 2026

From Energy Metal News

Via GlobeNewswire

Anaptys Announces First Quarter 2026 Financial Results and Provides Business Update

May 12, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Appoints Chris Murphy as Chief Financial Officer and Owen Hughes to Board of Directors

May 11, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio (NASDAQ:ANAB) Passes Minervini Trend Template and High Growth Momentum Screen ↗

May 02, 2026

Via Chartmill

ANAPTYBIO INC (NASDAQ:ANAB) Offers High-Growth Momentum and a Bullish Technical Setup ↗

January 23, 2026

Via Chartmill

ANAPTYSBIO INC (NASDAQ:ANAB) Shows Minervini Trend Template and High-Growth Momentum Alignment ↗

January 17, 2026

Via Chartmill

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

May 04, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Delaware Chancery Court Rules in Favor of Anaptys by Dismissing Tesaro’s Anticipatory Breach Claim

April 24, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Top movers analysis one hour before the close of the markets on 2026-04-20: top gainers and losers in today's session. ↗

April 20, 2026

Via Chartmill

What's going on in today's session ↗

April 20, 2026

Via Chartmill

These stocks are gapping in today's session ↗

April 20, 2026

Via Chartmill

Anaptys Completes Separation of First Tracks Biotherapeutics and Now Exclusively Manages GSK and Vanda Financial Collaborations

April 20, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Top movers in Monday's pre-market session ↗

April 20, 2026

Via Chartmill

Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

March 27, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

First Tracks Biotherapeutics, the Planned Spin-Off of Anaptys, Secures Commitments of $145 Million in Private Placement

March 27, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Provides Update on Business Separation and Announces Fourth Quarter and Full Year 2025 Financial Results

March 03, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys Announces Participation at Upcoming Investor Conferences

February 05, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

What This Insider Trim at AnaptysBio Means for Investors After a 260% Stock Rally ↗

January 11, 2026

Via The Motley Fool

What Investors Should Know About a $163K AnaptysBio Insider Sale ↗

January 11, 2026

Via The Motley Fool

Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK subsidiary

January 08, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

Anaptys to Present at the 44th Annual J.P. Morgan Healthcare Conference

January 06, 2026

From AnaptysBio, Inc.

Via GlobeNewswire

AnaptysBio Inc (NASDAQ:ANAB) Meets Minervini Trend Template with High-Growth Momentum ↗

December 20, 2025

Via Chartmill

Anaptys Announces Participation in December Investor Conferences

November 25, 2025

From AnaptysBio, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is AnaptysBio, Inc. - Common Stock publicly traded?

Yes, AnaptysBio, Inc. - Common Stock is publicly traded.

What exchange does AnaptysBio, Inc. - Common Stock trade on?

AnaptysBio, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for AnaptysBio, Inc. - Common Stock?

The ticker symbol for AnaptysBio, Inc. - Common Stock is ANAB on the Nasdaq Stock Market

What is the current price of AnaptysBio, Inc. - Common Stock?

The current price of AnaptysBio, Inc. - Common Stock is 55.84

When was AnaptysBio, Inc. - Common Stock last traded?

The last trade of AnaptysBio, Inc. - Common Stock was at 09/02/26 04:00 PM ET

What is the market capitalization of AnaptysBio, Inc. - Common Stock?

The market capitalization of AnaptysBio, Inc. - Common Stock is 1.53B

How many shares of AnaptysBio, Inc. - Common Stock are outstanding?

AnaptysBio, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.